Previous 10 | Next 10 |
The reviews for healthcare tech solutions provider Doximity 's (NYSE: DOCS) latest quarterly report came in this week in the form of analysts' price target adjustments. Some of these targets were raised and some were lowered, but ultimately, prognosticators who follow the company rema...
Shares of Doximity (NYSE: DOCS) dipped more than 10% the morning after it reported results from its fiscal third quarter that ended on Dec. 31, 2022. The company revised its forward-looking guidance downward, and the market made a knee-jerk reaction. Nobody likes to hear the companies...
Shares of Doximity (NYSE: DOCS) slumped Friday, tumbling as much 13.5%. As of 2:06 p.m. ET, the stock was still down 10%. The cloud-based networking platform for doctors and other healthcare professionals delivered financial results that beat expectations. At the same time managem...
Summary Doximity is now down over 60% from its all-time high in 2021. The healthcare technology company has huge market opportunities as the industry is poised for a transformation. Its Q3 earnings result was disappointing as revenue growth slowed while the operating margin also dec...
Doximity, Inc. (DOCS) Q3 2023 Earnings Conference Call February 9, 2023, 05:00 PM ET Company Participants Perry Gold - Head of IR Jeffrey Tangney - Co-Founder & CEO Anna Bryson - CFO Nate Gross - Co-Founder & Chief Scientific Officer Conference Call P...
Doximity ( NYSE: DOCS ), a digital platform for U.S. medical professionals, lost ~16% post-market Thursday after the company announced its Q3 FY23 results and lowered its outlook to stand below Street forecasts. San Francisco, California-based health platform expects its full-year...
Earns Top Marks for Culture, Loyalty, Ops, Product, Relationship and Value Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer, its popular telehealth platform, has been named 2023 ‘Best in KLAS’ in...
Doximity press release ( NYSE: DOCS ): Q3 Non-GAAP EPS of $0.22 beats by $0.05 . Revenue of $115.3M (+17.8% Y/Y) beats by $3.83M . Shares -8% . Doximity is providing guidance for its fiscal fourth quarter ending March 31, 2023 as follows: Revenue betwee...
Total revenues of $115.3 million, up 18% year-over-year Operating cash flow of $48.7 million, up 78% year-over-year Free cash flow of $47.5 million, up 85% year-over-year Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announce...
The shares for Doximity (NYSE: DOCS) , Iqvia Holdings (NYSE: IQV) , and TransMedics Group (NASDAQ: TMDX) are all off to positive starts this year, but what makes them different from other companies is that they are changing healthcare industry standards. Doximity i...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...